The application of pepsinogen I and pepsinogen II in screening for gastric cancer
Zhi-yi Tan
Abstract
Zhi-yi Tan
Abstract
Objective To explore the application of serum pepsinogen Ⅰ(PGⅠ),pepsinogen Ⅱ(PGⅡ)and corresponding PG ratio(PGR) in the screening of gastric cancer.Methods The concentration of PGⅠand PGⅡin 80 cases of gastric cancer,70 cases of atrophic gastritis,90 cases of gastric ulcer,80 cases of superficial gastritis and 100 healthy subjects were detected by latex enhanced immunoturbidimetric assay and calculating PGR.Results The concentration(ng/mL) of serum PGⅠin gastric cancer,atrophic gastritis,gastric ulcer,superficial gastritis and healthy control were(38.61±8.47),(43.16±8.88),(63.00±13.42),(48.10±4.62) and(56.21±7.60) respectively.The level of PGⅠin gastric cancer group and atrophic gastritis group were significantly lower than control group(P0.05).The concentration(ng/mL) of serum PGⅡwere(12.37±6.13),(13.01±5.17),(15.21±7.30),(8.02±4.03) and(10.89±3.81)respectively,there was no statistical difference among groups.The positive rates of PGⅠand PGⅡ in gastric cancer group and atrophic gastritis group were 92.50%,72.85% respectively,significantly higher than other groups(P0.05).Conclusion Detection of serum PGⅠand PGⅡ provides the evidence for screening and diagnosis of early gastric cancer and atrophic gastritis.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the application of serum pepsinogen Ⅰ(PGⅠ),pepsinogen Ⅱ(PGⅡ)and corresponding PG ratio(PGR) in the screening of gastric cancer.Methods The concentration of PGⅠand PGⅡin 80 cases of gastric cancer,70 cases of atrophic gastritis,90 cases of gastric ulcer,80 cases of superficial gastritis and 100 healthy subjects were detected by latex enhanced immunoturbidimetric assay and calculating PGR.Results The concentration(ng/mL) of serum PGⅠin gastric cancer,atrophic gastritis,gastric ulcer,superficial gastritis and healthy control were(38.61±8.47),(43.16±8.88),(63.00±13.42),(48.10±4.62) and(56.21±7.60) respectively.The level of PGⅠin gastric cancer group and atrophic gastritis group were significantly lower than control group(P0.05).The concentration(ng/mL) of serum PGⅡwere(12.37±6.13),(13.01±5.17),(15.21±7.30),(8.02±4.03) and(10.89±3.81)respectively,there was no statistical difference among groups.The positive rates of PGⅠand PGⅡ in gastric cancer group and atrophic gastritis group were 92.50%,72.85% respectively,significantly higher than other groups(P0.05).Conclusion Detection of serum PGⅠand PGⅡ provides the evidence for screening and diagnosis of early gastric cancer and atrophic gastritis.
Key concepts: Atrophic gastritis, Gastroenterology, Internal medicine, Pepsin, Medicine, Cancer, Gastritis, Significant difference